QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT

Clinical trial NCT07327788 · RECRUITING

Trial details

NCT number: NCT07327788
Sponsor: Nanfang Hospital, Southern Medical University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatecellular Carcinoma RALOX-HAIC（Hepatic Arterial Infusion Chemotherapy With Raltitrexed and Oxaliplatin Bevacizumab Type VP3/4 Portal Vein Tumor Thrombosis Iparomlimab and Tuvonralimab Injection QL1706

Start date: 2025-12-25
Primary completion: 2027-12-30
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.